Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
64.92
-0.57 (-0.87%)
At close: Feb 21, 2025, 4:00 PM
64.80
-0.12 (-0.18%)
After-hours: Feb 21, 2025, 6:15 PM EST
Bio-Techne Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Bio-Techne stock have an average target of 84.29, with a low estimate of 68 and a high estimate of 95. The average target predicts an increase of 29.84% from the current stock price of 64.92.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bio-Techne stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy → Hold Downgrades $88 → $68 | Buy → Hold | Downgrades | $88 → $68 | +4.74% | Feb 19, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $79 → $80 | Hold | Maintains | $79 → $80 | +23.23% | Feb 6, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $88 → $90 | Buy | Maintains | $88 → $90 | +38.63% | Feb 6, 2025 |
| Keybanc | Keybanc | Buy Maintains $80 → $90 | Buy | Maintains | $80 → $90 | +38.63% | Feb 6, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $83 → $88 | Buy | Maintains | $83 → $88 | +35.55% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
1.25B
from 1.16B
Increased by 7.50%
Revenue Next Year
1.36B
from 1.25B
Increased by 9.15%
EPS This Year
1.95
from 1.05
Increased by 85.82%
EPS Next Year
2.25
from 1.95
Increased by 15.23%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3B | 1.4B | 1.6B | ||
| Avg | 1.2B | 1.4B | 1.5B | ||
| Low | 1.2B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.4% | 15.2% | 19.0% | ||
| Avg | 7.5% | 9.1% | 11.5% | ||
| Low | 1.9% | 2.1% | 3.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.22 | 2.52 | 2.93 | ||
| Avg | 1.95 | 2.25 | 2.62 | ||
| Low | 1.82 | 1.96 | 2.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 111.0% | 29.2% | 30.3% | ||
| Avg | 85.8% | 15.2% | 16.5% | ||
| Low | 73.6% | 0.5% | 5.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.